Recently, in the bile duct ligation-induced liver cirrhosis (Sever et al., 2019), no portal hypertension development and reversal of the already preexisting portal hypertension to normal values (Sever et al., 2019) have become possible
AOD-9604 produces no IGF-1 elevation, potentially making it more appropriate for individuals with cancer history or elevated baseline cancer risk
the gelatin shell and enteric coating may degrade at higher temperatures
Before it was banned, a clean and pure BPC-157 supplement could be prescribed by a physician or compound pharmacist who knew about how it was made and what was inside, but now some grey market pharmaceutical companies may advertise BPC-157 without telling you fully what is in it, so its recommended to stay clear of anything currently being advertised as BPC-157
No clear evidence shows that AOD-9604 increases IGF-1 in the same way as full-length growth hormone